Patent foramen ovale closure by radiofrequency thermal coaptation: First experience in the porcine model and healing mechanisms over time

Circulation

Volumn 116, Issue 6, 2007, Pages 648-653

  Hara, Hidehiko ^a   Jones, Thomas K ^b   Ladich, Elena R ^c   Virmani, Renu ^c   Auth, David C ^d   Eichinger, Joseph E ^d   Sommer, Robert J ^e   Van Tassel, Robert A ^a   Schwartz, Robert S ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CVPATH INSTITUTE   (United States)

^d CoAptus Medical Corporation ^*  (United States)

^e Columbia University ^*  (United States)

Author keywords

Atheterization; Atrium; Pathology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOCARDIUM; HEART ATRIUM SEPTUM DEFECT; HISTOPATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY; SCAR FORMATION; SWINE; THROMBOGENESIS; ANIMAL; CATHETER ABLATION; COMPARATIVE STUDY; DISEASE MODEL; HEART SEPTUM DEFECT; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; TIME; WOUND HEALING;

ANIMALS; CATHETER ABLATION; DISEASE MODELS, ANIMAL; HEART SEPTAL DEFECTS, ATRIAL; SWINE; TIME FACTORS; WOUND HEALING;

EID: 34548162697     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.697276     Document Type: Article

References (21)

1. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139:753-760.
2. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus JL, Karnicki K, Stewart M, Pelzel JM, Schwartz RS. Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts. Catheter Cardiovasc Interv. 2007;69:266-273.
3. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol. 2006;48:161-169.
4. Sapp JL, Cooper JM, Zei P, Stevenson WG. Large radiofrequency ablation lesions can be created with a retractable infusion-needle catheter. J Cardiovasc Electrophysiol. 2006;17:657-661.
5. Cohnheim J. A general pathologic lecture. In: Thromb Embolism. 1877:134-137.
6. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992;117:461-465.
7. Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164:950-956.
8. Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47:64-66.
9. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97:1946-1951.
10. Kasper W, Geibel A, Tiede N, Just H. Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet. 1992;340:561-564.
11. Torti SR, Billinger M, Schwerzmann M, Vogel R, Zbinden R, Windecker S, Seiler C. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J. 2004;25:1014-1020.
12. Cartoni D, De Castro S, Valente G, Costanzo C, Pelliccia A, Beni S, Di Angelantonio E, Papetti F, Vitali Serdoz L, Fedele F. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am J Cardiol. 2004;94:270-273.
13. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493-495.
14. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol. 2005;45:489-492.
15. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, Tobis JM. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004;93:426-431.
16. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39:2019-2025.
17. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43:302-309.
18. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893-898.
19. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106:1121-1126.
20. Skowasch M. Revolutionary non-implant closure system for patent foramen ovale: first in human results. Circulation. 2005;112(suppl II):II-648. Abstract.
21. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46:1768-1776.